Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.780
-0.020 (-1.11%)
Jun 26, 2025, 12:36 PM - Market open
Outlook Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
Cash & Equivalents | 7.56 | 14.93 | 23.39 | 17.4 | 14.48 | 12.54 | Upgrade
|
Cash & Short-Term Investments | 7.56 | 14.93 | 23.39 | 17.4 | 14.48 | 12.54 | Upgrade
|
Cash Growth | -84.00% | -36.19% | 34.46% | 20.17% | 15.49% | 56.40% | Upgrade
|
Other Receivables | - | - | - | - | - | 0.8 | Upgrade
|
Receivables | - | - | - | - | - | 0.8 | Upgrade
|
Prepaid Expenses | 6.65 | 12.49 | 7.59 | 10.12 | 7.03 | 4.61 | Upgrade
|
Total Current Assets | 17.81 | 27.42 | 30.98 | 27.52 | 21.51 | 17.94 | Upgrade
|
Property, Plant & Equipment | 0.25 | 0.27 | 0.03 | 0.07 | 0.28 | 0.49 | Upgrade
|
Long-Term Investments | 0.62 | 0.69 | 0.79 | 0.8 | 0.85 | 0.9 | Upgrade
|
Long-Term Deferred Charges | 0.32 | 0.33 | - | 0.12 | - | - | Upgrade
|
Other Long-Term Assets | 0.07 | 0.11 | 0.5 | 0.01 | 0.17 | 0.39 | Upgrade
|
Total Assets | 19.08 | 28.82 | 32.3 | 28.53 | 22.81 | 19.73 | Upgrade
|
Accounts Payable | 7.77 | 7.97 | 6.57 | 3.49 | 2.2 | 2.39 | Upgrade
|
Accrued Expenses | 3.15 | 3.24 | 2.75 | 3.43 | 1.73 | 3.79 | Upgrade
|
Current Portion of Long-Term Debt | 12 | 29.44 | 35.55 | 10.92 | 0.9 | 3.66 | Upgrade
|
Current Portion of Leases | 0.05 | 0.05 | 0 | 0.04 | 0.07 | 0.22 | Upgrade
|
Current Income Taxes Payable | 1.86 | 1.86 | 1.86 | 1.86 | 1.86 | 1.86 | Upgrade
|
Other Current Liabilities | - | - | - | - | - | 3.97 | Upgrade
|
Total Current Liabilities | 24.82 | 42.55 | 46.73 | 19.73 | 6.75 | 15.89 | Upgrade
|
Long-Term Debt | 21.05 | - | - | - | 10.89 | 0.9 | Upgrade
|
Long-Term Leases | 0.22 | 0.25 | - | 0 | 0.04 | 0.04 | Upgrade
|
Other Long-Term Liabilities | 5.45 | 59.1 | 0.01 | 0.06 | 0.52 | 0.07 | Upgrade
|
Total Liabilities | 51.54 | 101.9 | 46.74 | 19.79 | 18.2 | 16.91 | Upgrade
|
Common Stock | 0.33 | 0.24 | 0.13 | 2.27 | 1.76 | 1.27 | Upgrade
|
Additional Paid-In Capital | 539.47 | 469.97 | 453.35 | 415.4 | 345.73 | 291.27 | Upgrade
|
Retained Earnings | -572.26 | -543.28 | -467.92 | -408.94 | -342.88 | -289.72 | Upgrade
|
Total Common Equity | -32.46 | -73.08 | -14.44 | 8.74 | 4.61 | 2.83 | Upgrade
|
Shareholders' Equity | -32.46 | -73.08 | -14.44 | 8.74 | 4.61 | 2.83 | Upgrade
|
Total Liabilities & Equity | 19.08 | 28.82 | 32.3 | 28.53 | 22.81 | 19.73 | Upgrade
|
Total Debt | 33.32 | 29.74 | 35.56 | 10.96 | 11.9 | 4.83 | Upgrade
|
Net Cash (Debt) | -25.76 | -14.81 | -12.16 | 6.44 | 2.57 | 7.71 | Upgrade
|
Net Cash Growth | - | - | - | 150.06% | -66.60% | - | Upgrade
|
Net Cash Per Share | -1.01 | -0.80 | -0.97 | 0.61 | 0.34 | 2.13 | Upgrade
|
Filing Date Shares Outstanding | 33.57 | 24.91 | 13.01 | 11.41 | 11.21 | 6.36 | Upgrade
|
Total Common Shares Outstanding | 32.91 | 23.91 | 13.01 | 11.37 | 8.82 | 6.36 | Upgrade
|
Working Capital | -7.02 | -15.14 | -15.75 | 7.79 | 14.76 | 2.06 | Upgrade
|
Book Value Per Share | -0.99 | -3.06 | -1.11 | 0.77 | 0.52 | 0.44 | Upgrade
|
Tangible Book Value | -32.46 | -73.08 | -14.44 | 8.74 | 4.61 | 2.83 | Upgrade
|
Tangible Book Value Per Share | -0.99 | -3.06 | -1.11 | 0.77 | 0.52 | 0.44 | Upgrade
|
Machinery | - | - | - | - | 1.07 | 1.07 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.